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Abstract 
Background: The precise role that CD8+ T cells play in the rejection and acceptance 
of different types of allograft is unclear and has been shown to vary between donor-
recipient combinations.   
Methods: The response of adoptively transferred CD8+ T cells reactive to the donor 
alloantigen H2Kb was examined after transplantation of H2Kb+ liver, kidney and heart 
grafts in mice.   
Results: Following transfer of 6x106 alloreactive CD8+ T cells to T-cell depleted 
syngeneic mice spontaneous long term acceptance of liver grafts was observed, 
whereas kidney and heart grafts were acutely rejected.  Within five days of liver 
transplantation we found that the entire H2Kb-reactive T cell pool was stimulated to 
proliferate and differentiate into memory/effector cells that were detectable within 
lymphoid tissues as well as the liver graft itself.  However, despite the generation of 
effector/memory T cells, liver allografts were accepted which correlated with the 
exhaustion/deletion of such cells.  In contrast, although activation and proliferation of 
H2Kb-reactive CD8+ T cells was observed after transplantation of heart or kidney 
grafts, unactivated, H2Kb-reactive CD8+ T cells were still present in the spleen even 
long term.  Interestingly, differences in the effector function of liver and kidney graft 
infiltrating donor-reactive CD8+ T cells were not detected after adoptive transfer into 
immunodeficient mice, despite a reduction in Th1-type cytokines within liver grafts.  
Conclusions: The rapid and extensive initial activation and differentiation of donor-
reactive CD8+ T cells that occurs after liver transplantation leads to clonal 
exhaustion/deletion of the alloreactive CD8+ T cell repertoire resulting in spontaneous 
tolerance induction. 
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Introduction 
CD8+ T cells with either helper or cytotoxic activity can play an important role in graft 
rejection. Indeed, in some situations, CD8+ T cells have been shown to reject 
vascularized and non vascularized allografts without help from CD4+ T cells (1), as 
well as contributing to responses in collaboration with other leukocyte populations.  In 
some mouse strain combinations it has been demonstrated that CD8+ T cells can 
trigger costimulation blockade resistant allograft rejection (2;3).  Administration of 
anti-CD154 mAbs led to prolongation of graft survival but not tolerance induction, 
unless the CD8 population was controlled independently by depletion or in some 
settings, tolerance induction (4).  Recent studies have revealed that CD8+ T cell–
mediated immune responses, including rejection and memory responses, can be 
influenced by regulatory CD4+ T cells (5-7).  Whether CD8+ T cells trigger tolerance 
or even play an active regulatory role in inducing unresponsiveness to donor 
alloantigens, independent of other cell populations, is not clear.  
 
Deletion of activated T cells through the process known as activation induced cell 
death (AICD) has been shown to contribute to reducing the frequency of donor 
reactive T cells, a step on the path to tolerance induction (8).  Deletion of cytotoxic T 
cells through AICD has been found to be one of the passive mechanisms involved in 
spontaneous graft acceptance and tolerance induction after liver transplantation 
(9;10).  Contributing factors include apoptosis inducing soluble MHC class I, secreted 
by the liver, as well as deletion by overstimulation and subsequent clonal exhaustion 
of the alloreactive cytotoxic cell population (11;12).  It has been suggested that the 
high alloantigen load delivered by the liver graft is responsible for the ‘high dose’ 
activation observed (13). This phenomenon was originally described for virus specific 
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cytotoxic effector T cells in the presence of persistent virus infection, and is therefore 
not restricted to host versus graft immunoresponses (14;15).  
 
In organ transplantation the exclusive ability of fully MHC mismatched liver grafts to 
induce spontaneous tolerance in animal models (16;17), in comparison to heart and 
kidney, underlines the significant role of location and pattern of antigen presentation 
for tolerance induction, provided here by the graft itself.  In addition, the finding in 
clinical liver transplantation that it is possible to wean a subgroup of liver transplant 
recipients off their immunosuppressive drug therapy confirms that the findings in 
animal models translates to the clinical setting (18;19).  In order to transpose the 
naturally occurring tolerogenic effects witnessed after liver transplantation into 
therapeutic possibilities of tolerogenic immunomodulation, a better and more detailed 
understanding of the T cell responses, including the proliferation and activation 
pattern as well as the degree of cell elimination and survival, is needed.     
 
To study the behaviour of alloreactive CD8+ T cells in a model of allograft acceptance 
and tolerance induction, we visualized the fate and function of adoptively transferred 
CFSE labelled alloantigen-reactive CD8+ T cells (BM3) after liver transplantation in a 
mouse model.  The changes observed were compared with those taking place after 
heart and kidney transplantation under the same conditions that have been shown 
previously to lead to rejection of a H2Kb+ heart graft (20). 
 
Materials and Methods 
Animals 
CBA/Ca (CBA;H2k) and C57BL/10 (B10;H2b) were originally purchased from Harlan 
Olac (Bicester, U.K.). CBA/RAG-1 knockout mice (mutation in the recombination 
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activating gene-1; H2k), which are totally deficient in mature T and B cells (21), were 
a kind gift from Dr. D.Kioussis (Mill Hill, London, U.K.), and BM3 TCR- transgenic 
mice (BM3; H2k) from Prof. A.L.Mellor (IMMG, Augusta, USA) (22).  All mice are now 
bred and housed in the SPF facilities of the Biomedical Services Unit, John Radcliffe 
Hospital (Oxford, U.K.). All donor and recipient mice were sex and age matched 
between 8 and 12 weeks at the time of transplantation and were treated in strict 
accordance with the Animals (Scientific Procedures) Act of 1986. 
Monoclonal Antibodies (mAbs) and Hybridomas 
YTA3.1 and YTS169 hybridomas were a gift from Professor H.Waldmann of the Sir 
William Dunn School of Pathology, Oxford University (23).  The Ti98 hybridoma was 
kindly provided by A.L.Mellor and described previously (24).  All hybridomas and cell 
lines were grown in either RPMI 1640 or -MEM (Life Technologies, U.K.), 
supplemented with 2 mM glutamine, antibiotics, and 10% (v/v) fetal calf serum (FCS; 
Life Technologies).  Anti-CD4 (YTA3.1) and anti-CD8 (YTS169) mAbs were purified 
and dialyzed into phosphate buffered saline (PBS) before being used in vivo.  Anti-
CD8-PerCp (53-6.7), anti-clonotypic TCR-biotin (Ti98), anti-CD44-PE (IM7), anti-
CD69-PE (A1.2F3) and anti-CD25-PE (PC61) mAbs were used in vitro for fluorescent 
activated cell sorter (FACS) analysis. Isotype-matched mAb R3-34-PE (rat IgG1) was 
used as control.  All mAbs were obtained from Pharmingen (Becton Dickinson, UK) 
unless stated otherwise. 
Surgical Procedures 
Orthotopic mouse liver transplantation was performed as previously described (25). 
Hepatic arterialization was not reconstructed.  Kidney grafts were transplanted 
orthotopically as described by Han et al. (26).  The remaining right recipient kidney 
was removed seven days after transplantation. Heterotopic heart transplantation was 
performed as documented by Corry et al. (27).  For skin transplantation full thickness 
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tail skin grafts were prepared to fit the graft bed on the lateral thorax of anesthetized 
recipients.  The grafts were inspected regularly until they were completely destroyed, 
at which time the grafts were considered to have been rejected.  Thymectomies were 
performed as previously described (20). 
Cell Purification and Labelling   
A single cell suspension was made from spleens and mesenteric lymph nodes 
harvested from BM3 TCR-transgenic mice.  CD8+ T cells were purified by positive 
selection using anti-CD8 MACS beads (Miltenyi Biotec, Germany).  Typically, CD8+ T 
cells were isolated to >95% purity.  More than 90% of the CD8+ T cells expressed the 
H2Kb-specific Tg-TCR.  The isolated cells were incubated for 10 minutes at 37°C with 
5M CFSE (Molecular Probes, The Netherlands) washed twice, and resuspended in 
PBS ready for i.v. injection. 
Standard experimental protocol 
CBA/Ca mice were thymectomized (day –24) and treated with depleting anti-CD4 
(YTA3.1; 100g/dose) and anti-CD8 (YTS169; 100g/dose) mAbs on day –17 and 
day –16.  For optimal depletion of the majority of T cells (95% T cell depletion on day 
–2) and clearance of the mAbs, the mice were rested for a further 14 days.  These 
“empty” immunocompromised mice were then reconstituted with an i.v. injection of 
the CFSE-labelled purified CD8+tg-TCR+ (BM3) T cells (day –2).  On day 0 mice 
received an H2Kb+ (C57BL/10) liver, kidney or heart allograft. 
Flow cytometric analysis 
Graft infiltrating leukocytes were isolated from liver, kidney and heart grafts by 
squeezing the organs through a sieve followed by enzymatic digestion for 30 min in 
37°C PBS with 0,02% collagenase IV and 0,002% DNase I (Sigma). Before cell 
isolation, the organs were washed out with saline to remove all circulating blood cells. 
Lymphoid cells were separated from the tissue suspension with a density gradient 
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centrifugation in 40% Percoll on a layer with 80% Percoll (Amersham, Uppsala, 
Sweden).  The interphase, enriched with lymhocytes, was finally washed in PBS. 
Then graft infiltrating cells, splenocytes and lymph node cells were stained with anti-
CD8-PerCp and Ti98-biotin mAbs.  After washing, a streptavidin-conjugated 
fluorochrome was added (streptavidin-APC (Pharmingen)).  The samples and 
fluorochrome were then incubated at 4°C before being washed twice.  Finally, the 
samples were stained with PE-labelled mAbs for detection of activation markers. All 
samples were immediately acquired on a FACSort (Becton Dickinson), and analyzed 
using the Cellquest software package (Becton Dickinson). 
Cytokine mRNA expression 
Grafted livers, kidneys and hearts as well as the spleens of recipients were analysed 
for the expression of mRNA encoding CD3, IFN-, IL-2, IL-4, IL-10, perforin and Fas 
Ligand (FasL) by employing quantitative real-time RT-PCR (TaqMan; PE Biosystems, 
CA).  RNA isolation and cDNA synthesis were performed as previously described 
(28).  The cDNA was then analysed for target gene expression by TaqMan PCR, 
using HPRT as a house keeping gene as described (28). The sequences of the 
oligonucleotides used are as follows:  
HPRT-sense5´-ATCATTATGCCGAGGATTTGGAA-3´,  
HPRT-antisense5´-TTGAGCACACAGAGGGCA-3´,  
HPRT-probe5´-TGGACAGGACTGAAAGACTTGCTCGAGATG-3´, 
CD3-sense5’-ATTGCGGGACAGGATGGAG-3’, 
CD3-antisense5’-CTTGGAGATGGCTGTACTGGTCA-3’, 
CD3-probe5’-TCGCCAGTCAAGAGCTTCAGACAAGCA-3’, 
IFN--sense5´-AGCAACAGCAAGGCGAAAAA-3´, 
IFN--antisense5´-AGCTCATTGAATGCTTGGCG-3´, 
IFN--probe5´-ATTGCCAAGTTTGAGGTCAACAACCCACA-3´, 
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IL-2-sense5’-CCCAGGATGCTCACCTTCAA-3’, 
IL-2-antisense5’-CATGCCGCAGAGGTCCAA-3’, 
IL-2-probe5’-CAATTCTGTGGCCTGCTTGGGCAA-3’, 
IL-4-sense5’-ATCGGCATTTTGAACGAGGTC-3’, 
IL-4-antisense5’-TCGTTGCTGTGAGGACGTTTG-3’, 
IL-4-probe5’-AGAAGGGACGCCATGCACGGAGA-3’, 
IL-10-sense5’-GAAGACCCTCAGGATGCGG-3’, 
IL-10-antisense5’-CCTGCTCCACTGCCTTGCT-3’, 
IL-10-probe5’-CGCTGTCATCGATTTCTCCCCTGTGA-3’, 
Perforin-sense5’-CAAGGTGGAGTGGAGGTTTTTGT-3’, 
Perforin-antisense5’-TTTTGCAGCTGAGAAGACCTATCA-3’, 
Perforin-probe5’-CCAGGCGAAAACTGTACATGCGACACT-3’, 
FasL-sense5’-GAAGGAACTGGCAGAACTCCG-3’, 
FasL-antisense5’-CCCTGTTAAATGGGCCACACT-3’, 
FasL-probe5’-AAAGCAAATAGCCAACCCCAGCACACC-3’. 
Sense and antisense oligonucleotides were purchased from MWG (Germany).  The 
probes were labelled with the reporter FAM (6-carboxyfluorescin) at the 5´ end and 
with the quencher TAMRA (6-carboxy-tetramethyl-rhodamine) at the 3´end and were 
purchased from Oswel (UK).  
Transfer of graft infiltrating cells and in vivo effector assay 
Graft infiltrating cells of liver and kidney grafts, as well as leucocytes from naive BM3 
transgenic mice were isolated as described above.  CD8+ T cells were purified from 
the suspension by positive selection using anti-CD8 MACS beads (Miltenyi Biotec).  
Purity was >95%.  CFSE negative cells were isolated out of this population on a 
FACStar cell sorter (BD Biosciences, CA) with a purity of >99%.  CD8+ graft 
infiltrating cells and naive CD8+BM3+ cells each were then adoptively transferred into 
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immunodeficient CBA/RAG1-/- mice.  Donor B10 skin grafts were transplanted on the 
following day, and the survival rate of these grafts was measured as an indicator of 
rejection potency of the transferred CD8+ cells. 
Immunohistochemistry 
Cryostat sections (6m) were air-dried and then fixed in acetone for 10 min. After 
inhibition of endogenous peroxidase activity and blockade of endogenous biotin  
sections were incubated with an anti-CD8-biotin mAb (BD-Biosciences) for 1h at 
room temperature. Binding was detected by an avidin biotin-peroxidase complex 
(ABC, Vector Laboratories) and visualized using diaminobenzidene (Sigma-Aldrich) 
and Gill’s hematoxylin (BDH). 
Statistics 
Results are given as mean  SD.  Data were compared and analysed using an 
unpaired two-tailed Student’s t test.  The Wilcoxon test was used for comparison of 
survival data.  A p-value of <0.05 was considered significant.  
 
 
Results 
Survival of allogeneic mouse liver, kidney and heart transplants.  
To compare the response of non immunocompromised naive mice possessing the 
full repertoire of CD4+ and CD8+ T cells to three different fully allogeneic vascularized 
organ grafts, the survival of B10 (H2b) liver, kidney or heart grafts transplanted into 
CBA/Ca (H2k) recipients was examined.  95% of liver grafts were accepted for more 
then 100 days, while in marked contrast, kidney or heart grafts from the same donor 
strain were rejected acutely, within 10 days after transplantation (Figure 1). 
 
Susceptibility of solid organ grafts to rejection mediated by alloreactive CD8+ T cells. 
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In order to be able to dissect the impact of transplantation of different types of graft 
on a defined population of T cells, we next investigated whether the same differences 
in graft survival were observed when the T cell repertoire comprised only CD8+ T 
cells reactive to a donor MHC class I alloantigen H2Kb.  T cell deficient CBA/Ca mice, 
i.e. depleted of CD8+ and CD4+ T cells that accept liver, kidney and heart grafts in the 
absence of T cell reconstitution (1), were adoptively transferred with 6x106 H2Kb-
reactive BM3 T cells two days before transplantation of a H2Kb+ liver or kidney graft 
(Table 1). 4 out of 5 liver recipients survived long term, whereas all recipients of an 
allogeneic kidney graft rejected the kidney within 37 days.  Decreasing the number of 
H2Kb-reactive T cells transferred revealed that the susceptibility of kidney grafts to 
rejection was related to the number of CD8+ T cell transferred; transfer of 4x106 cells 
led to a long term survival of 3 out of 4 recipients after transplantation of kidney 
grafts.  A similar threshold between graft rejection and acceptance seen after 
allogeneic mouse heart transplantation has also been described (1).   
Additional B10 liver grafts were transplanted into native BM3 TCR-transgenic mice 
i.e. where the whole T cell repertoire comprises of H2Kb-reactive CD8+ T cells and as 
such far exceeding the 6x106 cells adoptively transferred above.  Even under these 
conditions long term liver graft acceptance was observed. In contrast, primary B10 
kidney grafts were acutely rejected under the same conditions within 10 days 
(Table.1).  
 
Activation and proliferation of alloreactive CD8+ T cells after liver, kidney and heart 
transplantation. 
To monitor the proliferation and activation pattern of the adoptively transferred 
alloreactive CD8+ T cells after transplantation we used the model described above, 
utilising the adoptive transfer of BM3 CD8+ T cells labelled with CFSE before transfer.  
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Analysis of H2Kb-specific T cells 5 days after liver transplantation revealed that 
93.4% of BM3 T cells in the spleen had divided more than 4 times.  In contrast, after 
kidney and heart transplantation only 27.3% and 16.3% of the H2Kb-reactive CD8+ 
population in the spleen had divided more than four times respectively.  Following 
transplantation of syngeneic grafts no proliferation of alloreactive BM3 T cells was 
observed after either liver or kidney transplantation (data not shown).  In each setting, 
after 2-3 divisions, the proliferating cells differentiated into a CD44high-phenotype, a 
marker associated with antigen experience and effector function.  Thus, most of the 
H2Kb-reactive T cells isolated from spleen five days after liver transplantation had 
already acquired an activated phenotype (Figure 2a). Expression of CD69 and CD25 
was used to identify activated cells independent of their pattern of proliferation, 
however, no significant upregulation of either marker on H2Kb-specific BM3 T cells 
was detectable in the spleen of liver, kidney or heart recipients (data not shown).  
Similar proliferation and differentiation patterns were also observed in the mesenteric 
lymph nodes 5 days after transplantation (data not shown).  
 
To obtain more information about the role and behaviour of donor-reactive CD8+ T 
cells at arguably the most important location i.e. the graft itself, graft infiltrating 
lymphocytes were isolated from allogeneic liver, kidney and heart grafts 5 days after 
transplantation (Figure 2b). In contrast to the proliferation pattern observed in the 
peripheral lymphoid organs, the percentage of BM3 T cells that had undergone 5 or 
more divisions was much higher amongst the graft infiltrating cells isolated from all 
three different types of grafts.  While no undivided donor-reactive CD8+ T cells were 
detectable in liver grafts, a higher percentage of H2Kb-specific T cells showing fewer 
than five divisions were present in kidney and heart allografts.  These undivided, or 
less divided cells, predominantly expressed a CD44lowCD69high-phenotype, which 
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linked to recent activation, whereas T cells with more than four divisions were 
characterized by the expression of a CD44highCD69low-phenotype (Figure 2b).  
 
Expression of CD3 mRNA compared to the house keeping gene HPRT was used as 
a surrogate marker to quantitate T cell infiltration into the graft.  Interestingly, the 
relationship between T cells and the remaining resident organ cells present in kidney 
and heart grafts was found to be higher that present in allogeneic liver grafts 5 days 
after transplantation (Figure 3a), despite a 3 fold increase in the absolute cell 
number of infiltrating alloreactive CD8+ T cells in liver grafts in comparison to kidney 
grafts (Figure 3b). This observation was confirmed by staining liver, kidney and heart 
allografts for expression of CD8 5 days after transplantation.  In liver grafts, an 
intensive infiltration by CD8+ T cells was confined to portal areas without further 
damage to hepatocytes or endothelium inside the lobuli, whereas the infiltration of 
kidney and heart grafts was diffuse and widespreaded throughout the transplanted 
organ (Figure 3c).  This discrepancy in the pattern of T cell infiltration may be 
explained by a lack of adhesion molecules inside the liver sinusoids (29).  
To clarify whether the rapid proliferation of donor reactive CD8+ T cells triggered by a 
liver transplant led to elimination of the donor reactive T cell pool, the number of graft 
infiltrating and splenic H2Kb-specific T cells was determined 5 and 15 days after liver 
transplantation and compared to the absolute cell numbers of alloreactive T cells in 
heart and kidney recipients. We found that 5 days after transplantation, 1.4x106  
donor reactive graft infiltrating CD8+ T cells were detected after liver transplantation, 
whereas only 0.42x106 and 0.09x106 graft infiltrating BM3 T cells were isolated 
following kidney and heart transplantation, respectively confirming the more rapid 
activation and expansion of BM3 T cells following liver transplantation.  In clear 
contrast, analysis of liver graft recipients 15 days after transplantation revealed that 
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rather than increasing the number of infiltrating BM3 T cells had fallen to 0.66x106 
which was mirrored in the peripheral lymphoid tissues where the number of BM3 T 
cells decreased 6 fold (Figure 3b). 
  
Cytokine expression in spleen and graft 
We hypothesised that a shift from initial hyperresponsiveness to unresponsiveness 
may also be necessary for graft acceptance after liver transplantation.  To test this 
hypothesis, cytokine mRNA expression of Th1 and Th2 associated cytokines as well 
as, the cytotoxic molecules perforin and FasL were measured in the graft and spleen 
five days after transplantation (Figure 4).  
Expression of IFN- mRNA in liver grafts was found to be significantly reduced 
compared to that found in either heart and kidney grafts 5 days after transplantation.  
In addition, IL-2 mRNA expression showed a trend towards downregulation in the 
liver grafts, but the differences were not significant.  Surprisingly, there was a marked 
downregulation of IL-10 mRNA expression in kidney grafts, in comparison with hearts 
and livers. Differences in IL-4 mRNA expression were not significant, but showed 
higher expression in liver grafts (Figure 4a).  Interestingly, the lowest expression of 
perforin and FasL mRNA was detectable in liver grafts 5 days after transplantation 
with the highest expression being detectable in heart grafts.  No significant 
differences were found in the spleen for all of these molecules 5 days after 
transplantation (Figure 4b).  
 
Effector potential of graft infiltrating cells 
We postulated that the low expression of IFN-, perforin and FasL mRNA in liver 
allografts, as well as the persistence of donor-reactive T cells, was due to liver 
infiltrating donor-reactive T cells being in a state of unresponsiveness, whereas 
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donor-reactive T cells infiltrating kidney or heart grafts 5 days after transplantation 
had full effector function.  To test this hypothesis, graft infiltrating cells were isolated 
from liver and kidney transplants and transferred into immunodeficient CBA/RAG1-/- 
mice whereupon their ability to mediate rejection of donor B10 skin grafts was 
assessed. We first confirmed the number of naïve H2Kb-specific CD8+ T cells 
required to reject a B10 H2Kb+ skin allograft.  To this end, 0.2 to 5x105 naive BM3 T 
cells were transferred to CBA/RAG-/- recipients that were subsequently transplanted 
with donor-type B10 skin grafts.  As few as 2x104 naive H2Kb-reactive CD8+ T cells 
were found to be sufficient to reject B10 skin grafts in less than 20 days (Figure 5a).  
Transfer of 2x105 graft infiltrating CD8+ T cells from liver allografts, i.e. 10 times the 
number of naïve T cells required to trigger rejection, resulted in the prolonged 
survival of B10 skin grafts, although all grafts were rejected by 72 days after 
transplantation.  Surprisingly, adoptive transfer of 2x105 CD8+ graft infiltrating cells 
isolated from kidney allografts 5 days after transplantation also resulted in extended 
graft survival (Figure 5b). The alloreactivity of graft infiltrating T cells from liver 
allografts seems to be reduced compared to cells isolated from kidney grafts, but 
significance could not be proved.  To rule out the potential contribution of freshly 
activated and proliferating T cells (CD44lowCD69high and CFSE positive), 2x105 CFSE 
negative graft infiltrating T cells from kidney allografts (ie >5 cell divisions) were 
isolated by cell sorting and adoptively transferred into CBA/RAG1-/- mice.  In these 
mice H2Kb+ skin grafts were rejected with a MST of 47.5 days (n=4). Thus, 
independent of their activation or differentiation status, graft infiltrating T cells, 
isolated from spontaneously accepted liver or rejected kidney grafts retain the 
potential to reject allogeneic tissue. 
Steger et al  17 
Discussion 
Transplantation of a fully allogeneic liver graft can lead to spontaneous graft 
acceptance in naive immunocompetent recipients (17).  In contrast to previous 
studies (30), where spontaneous kidney graft acceptance has also been described 
(31), B10 renal allografts were acutely rejected when transplanted to CBA/Ca 
recipients in the study reported here without any exceptions with similar kinetics to 
that of heart allografts.  Moreover, the threshold for the susceptibility of heart and 
kidney allografts to rejection driven by donor reactive CD8+ T cells was very similar 
(see Table1 and Jones et al. 2001 (1)), whereas liver grafts were not found to be 
susceptible to rejection under the same conditions. Previous work from our group 
demonstrated a decreasing susceptibility of islet, skin and heart grafts to rejection 
mediated by donor reactive CD8+ T cells (1).  Kidney grafts, that have an organ mass 
approximately comparable to that of heart grafts, were also unable to resist 
destruction mediated by 6x106 donor-reactive T cells, whereas liver grafts with a 
much larger mass were accepted under the same conditions (Table 1).  This 
relationship between the mass of donor tissue transplanted and rejection or 
acceptance has previously been demonstrated in studies showing that simultaneous 
transplantation of two kidneys and two hearts resulted in long term graft acceptance, 
whereas single allogeneic heart and kidney graft were rejected acutely (13).  One 
explanation that has been proposed to account for these findings is that the antigen 
load provided by a large amount of transplantated donor tissue, causes hyper- or 
overstimulation of donor reactive leukocytes present in the recipient (32).  Our 
findings support this hypothesis as, visualization of the proliferative pattern of donor-
reactive T cells at day 5 after transplantation demonstrated that liver allografts 
triggered early hyperstimulation of donor-reactive T cells with a much higher 
proportion of the donor-reactive T cell pool undergoing more then four divisions 
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compared to that observed after transplantation of a kidney or heart allograft (Figure 
2).   
 
Deletion of donor-reactive T cells has been postulated to be a significant factor in the 
induction of tolerance leading to the spontaneous graft acceptance as high rates of T 
cell apoptosis have been observed after liver transplantation in mouse and rat 
models (9;33).  The liver has been reported to have special properties in this regard 
(34;35), despite recent findings that intrahepatic activation by local antigen 
presentation to CD8+ T cells resulted not in abortive interactions, failed maturation or 
premature T cell death (36).  However, a rapid deletion of the entire activated 
alloreactive T cell pool inside the liver graft seems to be not the case, since 5 days 
after transplantation more than one million donor reactive CD8+ T cells remained 
inside the graft, and even after 15 days approximately half a million donor reactive 
cells were still detectable inside the liver grafts.  Nevertheless we found that the 
absolute number of alloreactive CD8+ T cells, especially in the spleen, decreased 
after liver transplantation in comparison to recipients of heart grafts over the time ((1), 
Figure 3). 
 
The anergic environment inside the accepted liver grafts - despite a significant 
amount of remaining alloreactive T cells in the graft - was mirrored by the low mRNA 
expression of IFN-, IL-2, and especially the cytotoxic-molecules perforin and FasL 
inside the grafts 5 days after transplantation in comparison to kidney and heart 
allografts undergoing acute rejection.  The changes of interleukin-expression could 
be explained in part by the complete and extensive proliferation of donor reactive T 
cells inside liver grafts and the attendant changes in cytokine expression by 
progressive cell division, but the low level of IFN-is uncharacteristic and not 
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observed even after 8 rounds of division after in vitro stimulation of naive T cells (37). 
This discrepancy may be explained by the differences between intracellular staining, 
where cells are restimulated ex vivo prior to the staining process (revealing what 
cytokines may be produced following activation), and the technique used here of 
mRNA-expression (detecting the potential cytokines that are being produced in situ in 
the graft (albeit at the gene and not protein level). In addition a limited application of 
intracellular staining of cytokines for the differentiation between graft acceptance and 
rejection was shown by our group before (38).  
 
Unresponsiveness of the liver graft infiltrating CD8+ T cells seems to be unlikely due 
to the remaining ability of these cells to reject a skin graft after adoptive transfer into 
a secondary host (Figure 5).  However it could be possible that initial anergic T cells 
were partially reactivated in the presence of inflammatory signals created by the 
transplantation of the challenge skin graft.  The phenomenon of split anergy, 
describing receptor-dependent cytolysis in the absence of IL-2 production (39) is 
most likely responsible for a distinct difference between intragraft cytokine expression 
and functional behaviour after adoptive transfer to a fresh host in vivo.  A 
phenomenon similar to this, called split tolerance, has already been observed after 
mouse liver transplantation, where long term surviving grafts still possessed CTLs 
with donor specific cytotoxic potential in vitro (40).  
 
The rapid and extensive activation of the donor reactive CD8+ T cells in the initial 
period after transplantation followed by deletion of the alloreactive T cell repertoire 
inside the peripheral lymphatic tissues was the major difference in the response of 
donor reactive cells after liver transplantation compared to the response of the same 
population of T cells after heart and kidney transplantation.  These findings support 
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the hypothesis that initial hyperstimulation by infusion of additional donor alloantigen 
(41-43) might create a beneficial window for immunological engagement facilitating 
the induction of unresponsiveness (44).  However the perfect time frame and load of 
alloantigen required has still to be defined. 
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Tables 
 
 
 
Table 1:  Survival time of solid organ allografts 
 
 
 
 
 
 
    Liver Transplantation Kidney Transplantation 
 
B10BM3   5 x >60 d   8, 8, 9, 10 d (MST:8,5d) 
 
B10CBA (6x106 BM3) 5, 4 x >60 d   10, 27, 33, 37 d (MST: 30d) 
 
B10CBA (4x106 BM3) - - -     38, 3 x >60d 
 
B10CBA (No BM3)  4 x >60 d   8, 4 x >60 d 
 
 
 
 
 
Table 1: Survival time of different solid C57BL/10 organ grafts in T-cell depleted CBA 
mice that have received either 4 or 6x106 TCR-transgenic BM3 CD8+ T cells, or 
unmanipulated BM3 mice. (MST=Median Survival Time). 
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Figure Legends 
 
Figure 1: Survival rate after mouse liver (LTx), kidney (KTx) and heart (HTx) 
transplantation of C57BL/10 organ grafts (H-2b) in naive unmanipulated CBA/Ca-
recipients (H-2k). LTx: MST>100 days, n=20, KTx:  MST=9 days, n=8; HTx: MST=7 
days, n=12).   
 
Figure 2: To characterize the division kinetics, H2Kb-specific T cells were labelled 
with CFSE. Cells stained with the fluorescein dye CFSE have been shown to lose 
half of their intensity with each cell division, which can be monitored by flow 
cytometry (45).  By using four colour flow cytometry and gating on CD8+ tg-TCR+ 
(TI98) cells, it was possible to visualize this single alloreactive cell population 
independently of other cells, as described recently in more detail (20).  a) 
Proliferation of alloreactive CD8+T cells, isolated seven days after adoptive transfer 
(AT only) or five days after liver (LTx), kidney (KTx) and heart (HTx) transplantation 
from spleens of immunocompromised CBA recipients, transferred with 6x106 H2Kb-
specific T cells at day –2.  Percentage of cells with more then 4 cell divisions 
(n=3/group) and the CD44 expression dependent on their proliferation status. b) 
Proliferation and CD44 / CD69 expression of graft infiltrating alloreactive CD8+T cells 
(GIC) labelled with CFSE and transferred to immunocompromised CBA recipients at 
day -2 and isolated 5 days after liver, kidney and heart transplantation. Percentages 
of CD8+T cells with more than 4 cell divisions (n=3/group.). Dotplots are 
representative for 3 different recipients per organ (GICs of hearts were pooled for 
phenotype analysis). 
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Figure 3: a) Expression of CD3 mRNA, as an indicator of T cell infiltrating intensity in 
graft and spleen, five days after liver, kidney and heart transplantation, was 
measured by real-time RT-PCR (n=3). Results are expressed as mRNA (units/HPRT) 
 SD. b) The absolute cell numbers of alloreactive T cells inside grafts and spleens 
were measured at day 5 and 15 after transplantation by counting the total leukocyte 
number of each organ using trypan blue exclusion. The leukocytes were then stained 
for expression of CD8 and the tg-TCR and the percentage of these cells was 
determined by FACS analysis. The percentage and total leukocyte count were then 
used to calculate the absolute cell number of CD8+tg-TCR+ cells per organ. Cell 
numbers are demonstrated in million (x106) as mean  SD. Three mice were used 
per group (except day 15 liver: n=2, GIC of heart grafts were pooled). c) Histology of 
heart, kidney and liver allografts five days after transplantation and 7 days after 
adoptive transfer of alloreactive CD8+ T. Sections were stained with anti-CD8 mAb to 
reveal the infiltration of BM3 T cells into the grafts (magnification 100x liver, 200x 
kidney and heart graft)  
 
Figure 4: mRNA expression of T cell related cytokines and cytolytic molecules in 
allografts and spleens 7 days after transfer of 6x106 alloreactive CD8+T-cells into 
immunocompromised CBA mice and 5 days after allogeneic liver, kidney and heart 
transplantation, measured by quantitative real-time RT-PCR. a) mRNA of Th1 and 
Th2 related cytokines IFN-, IL-2, IL-4 and IL-10 were measured in tissues of 
infiltrated allografts and recipient spleens relative to CD3 expression. b) Expression 
of cytolytic effector protein perforin and the cytolytic ligand of the Fas receptor (FasL), 
both complementary for the killing activity of cytotoxic T cells, in grafts and spleens 
five days after liver, kidney and heart transplantation. 3 different recipients were used 
per organ. Significant differences are marked with * (p < 0.05). 
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Figure 5: Survival rate of C57BL/10 skin grafts after transfer of a) 0.2 - 5x105 naive 
or b) 2x105 liver / kidney graft infiltrating Ti98+CD8+ T cells (GIC; postoperative day 
5) at day -1 into immunodeficient CBA/RAG1-/- mice. MST: 59.5 days with cells from 
liver grafts; n=4 vs 41.5 days; n=4 with cells from kidney allografts (Difference is not 
significant; 100% survival rate of B10 skin grafts on CBA/RAG1-/- mice without T cell 
transfer, n=4, data not shown)  
 
 
